ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
10.50
+0.40 (3.96%)
Feb 13, 2026, 12:55 PM EST

ZIVO Bioscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.061.540.271.88.90.14
Cash & Short-Term Investments
0.061.540.271.88.90.14
Cash Growth
-64.10%462.16%-84.75%-79.79%6357.09%-60.17%
Receivables
-00---
Prepaid Expenses
0.220.090.150.10.060.03
Total Current Assets
0.281.640.431.98.960.17
Property, Plant & Equipment
0.27-0.10.190.030.05
Other Long-Term Assets
0.010.010.030.0300
Total Assets
0.561.640.562.128.990.22
Accounts Payable
1.330.741.170.490.651.56
Accrued Expenses
1.691.161.250.50.562.68
Short-Term Debt
0.15----0.01
Current Portion of Long-Term Debt
0.380.140.240.240.245.18
Current Portion of Leases
0.07-0.110.10.020.03
Current Unearned Revenue
---0.71.481.94
Total Current Liabilities
3.612.042.762.032.9511.39
Long-Term Debt
0.010.12---0.12
Long-Term Leases
0.22--0.11-0.02
Total Liabilities
3.852.162.762.132.9511.53
Common Stock
00000.010.01
Additional Paid-In Capital
140.56136.45121.37115.79113.0987.75
Retained Earnings
-143.85-136.97-123.58-115.8-107.06-99.06
Shareholders' Equity
-3.29-0.51-2.21-0.016.04-11.31
Total Liabilities & Equity
0.561.640.562.128.990.22
Total Debt
0.820.250.350.450.265.36
Net Cash (Debt)
-0.761.29-0.071.358.65-5.22
Net Cash Growth
----84.34%--
Net Cash Per Share
-0.200.41-0.040.866.80-6.17
Filing Date Shares Outstanding
3.893.762.781.571.570.87
Total Common Shares Outstanding
3.833.622.381.571.570.83
Working Capital
-3.33-0.41-2.34-0.136.01-11.23
Book Value Per Share
-0.86-0.14-0.93-0.013.85-13.68
Tangible Book Value
-3.29-0.51-2.21-0.016.04-11.31
Tangible Book Value Per Share
-0.86-0.14-0.93-0.013.85-13.68
Machinery
-----0.1
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.